ABITEC Corporation
Donald Kelemen has extensive experience in corporate and business development, with a focus on the biopharmaceutical industry. Donald started their career at Amylin Pharmaceuticals in 2001, where they were involved in business and corporate development as well as new product planning. From 2006 to 2009, they worked at PATH-MVI as the Head of Business Development. Donald then joined ABITEC Corporation in 2009 as the Global Business Director. After a short period at Gennova Biopharmaceuticals as the Vice President of Business Development and Corporate Strategy, they returned to ABITEC Corporation in 2013 as the Head of Corporate and Business Development.
Donald Kelemen received their Ph.D in Nutrition and Biotechnology from North Carolina State University, where they attended from 1986 to 1994.
ABITEC Corporation
1 followers
ABITEC is a world leader in the development of lipids and specialty ingredients for the pharmaceutical, nutraceutical, and specialty chemical industries. For more than 50 years, ABITEC has utilized its technical expertise to create diverse and versatile product lines that meet a wide range of formulating challenges. Additional capabilities include: • Esterification & transesterification • Quarterization, alkoxylation, ethoxylation & propoxylation • Glycerolysis • Fractional/short-path distillation • Crystallization • Blending As part of ABF Ingredients, a division of Associated British Foods plc, we have the advantage of cooperative efforts with other ABF Ingredients companies and the ability to reach across the world to provide a broad spectrum of products for your specific needs.